Related Experiment Videos
Vaccine-induced polioencephalomyelitis in Scotland
A A Asindi1, E J Bell, M J Browning
1Fraser of Allander Unit (Paediatric Neurology), Royal Hospital for Sick Children, Glasgow.
Scottish Medical Journal
|August 1, 1988
Summary
This case report details a rare instance of vaccine-associated paralytic poliomyelitis in Scotland, linked to oral poliovirus vaccination. The findings highlight the need for careful investigation of vaccine-related adverse events.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Immunology
Background:
- The use of oral poliovirus vaccine (OPV) has been instrumental in polio eradication efforts.
- However, vaccine-associated paralytic poliomyelitis (VAPP) remains a rare but serious complication.
- Understanding the risk factors and presentation of VAPP is crucial for public health surveillance.
Observation:
- A six-month-old infant presented with fever and progressive paralysis following OPV and DTP vaccination.
- Clinical examination revealed limb and facial paralysis, diaphragmatic weakness, scoliosis, opsoclonus, and ocular flutter.
- Poliovirus isolates from stool were vaccine-like strains (types 1, 2, and 3).
Findings:
- The patient exhibited persistently low serum IgA levels and undetectable salivary IgA.
- This case is the first authenticated report of poliovaccine damage in Scotland.
- The potential role of selective IgA deficiency in the patient's vulnerability is considered but remains unclear.
Implications:
- Thorough investigation of viral isolates in suspected poliomyelitis cases is essential.
- This case underscores the importance of monitoring and understanding the ramifications of poliovaccine damage.
- Addressing public apprehension regarding vaccine safety requires transparent reporting and investigation of adverse events.